The mechanisms underlying the antitumor activity of aspirin remain hypothetical and complex, yet it may be one of the critical mechanisms that the antitumor effect of aspirin on CRC targets nuclear factor- κB (NF-κB), the transcription factor10,11. Here, NFKB1 is linked to colorectal carcinoma.